XML 63 R47.htm IDEA: XBRL DOCUMENT
v3.25.3

Stock-Based Compensation (Tables) | 12 Months Ended
--- | ---
Sep. 27, 2025
Share-Based Payment Arrangement, Noncash Expense [Abstract] |
Schedule of Summary of Stock Options |
| Shares Under Option |  | Weighted Average Exercise Price Per Share |  | Weighted Average Remaining Contractual Life (in Years) |  | Aggregate Intrinsic Value (in millions)
Outstanding, September 28, 2024 | 7,114,663 |  |  | $ | 64.02 |  |  |  |  |
Exercised | (669,987) |  |  | 49.82 |  |  |  |  |
Forfeited or expired | (623,291) |  |  | 66.64 |  |  |  |  |
Granted | 1,648,774 |  |  | 64.54 |  |  |  |  |
Outstanding, September 27, 2025 | 7,470,159 |  |  | $ | 65.19 |  |  | 6.4 |  | $ | 9 |
Exercisable, September 27, 2025 | 4,851,416 |  |  | $ | 68.57 |  |  | 5.2 |  | $ | 4 |
Schedule of Assumptions of Fair Value Calculation of Each Year's Grants | Assumptions used in the fair value calculation are as of the grant dates and are outlined in the following table.
| 2025 |  | 2024 |  | 2023
Expected life (in years) | 4.6 |  | 4.5 |  | 4.5
Risk-free interest rate | 4.2 | % |  | 4.5 | % |  | 3.9 | %
Expected volatility | 26.8 | % |  | 31.9 | % |  | 31.2 | %
Expected dividend yield | 3.0 | % |  | 2.7 | % |  | 2.9 | %
Schedule of Summary of Restricted Stock |
| Number of Shares or Units |  | Weighted Average Grant- Date Fair Value Per Share/Unit |  | Weighted Average Remaining Contractual Life (in Years) |  | Aggregate Intrinsic Value (in millions)
Nonvested, September 28, 2024 | 1,866,591 |  |  | $ | 59.35 |  |  |  |  |
Granted | 818,233 |  |  | 63.49 |  |  |  |  |
Dividends | 65,562 |  |  | 59.72 |  |  |  |  |
Vested | (862,968) |  |  | 63.70 |  |  |  |  |
Forfeited | (191,133) |  |  | 58.38 |  |  |  |  |
Nonvested, September 27, 2025 | 1,696,285 |  |  | $ | 59.26 |  |  | 1.4 |  | $ | 92 |
Schedule of Summary of Performance-Based Shares | The following table summarizes the performance-based shares at the maximum award amounts based upon the respective performance share agreements. Actual shares that will vest depend on the level of attainment of the performance-based criteria.
| Number of Shares |  | Weighted Average Grant- Date Fair Value Per Share |  | Weighted Average Remaining Contractual Life (in Years) |  | Aggregate Intrinsic Value (in millions)
Nonvested, September 28, 2024 | 2,375,302 |  |  | $ | 46.57 |  |  |  |  |
Granted | 993,144 |  |  | 54.42 |  |  |  |  |
Vested | (220,933) |  |  | 48.74 |  |  |  |  |
Forfeited | (651,623) |  |  | 57.58 |  |  |  |  |
Nonvested, September 27, 2025 | 2,495,890 |  |  | $ | 46.63 |  |  | 1.3 |  | $ | 135 |

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_ShareBasedCompensationAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average grant date fair value for outstanding performance shares. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Subparagraph (c) -Paragraph 2 -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration